Together with the reduction in the expression of CCL19 and CCL21 in response to IR, these findings strongly indicate that DLN IR disrupts immune cell trafficking into the lymph nodes and consequently interferes with tumor IR-induced T cell priming, which is a crucial mechanism behind combined efficacy of radiotherapy and immunotherapy4. This evidence concerns the gene CCL19 and neoplasm.